Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlycoMimetics

0.2637
+0.00411.58%
Post-market: 0.2430-0.0207-7.85%19:37 EDT
Volume:169.94K
Turnover:45.23K
Market Cap:17.01M
PE:-0.45
High:0.2730
Open:0.2670
Low:0.2630
Close:0.2596
Loading ...

BRIEF-GlycoMimetics Says Following Termination, Co Will Not Have Any Material Financial Or Other Obligations Under Agreement

Reuters
·
26 Feb

GlycoMimetics : on Feb 19, Received Notice From Apollomics (Hong Kong) Limited Terminating Collaboration and License Agreement

THOMSON REUTERS
·
26 Feb

GlycoMimetics : Following Termination, Co Will Not Have Any Material Financial or Other Obligations Under Agreement

THOMSON REUTERS
·
26 Feb

GlycoMimetics Inc - Amended Agreement for $200 Million Purchase of Crescent Securities

THOMSON REUTERS
·
15 Feb

GlycoMimetics Inc - Co and Crescent Biopharma Amend Merger Agreement

THOMSON REUTERS
·
15 Feb

BRIEF-Glycomimetics Inc Says CEO Harout Semerjian And CFO Brian Hahn To Step Down

Reuters
·
01 Feb

GlycoMimetics Inc - CEO Harout Semerjian and CFO Brian Hahn to Step Down

THOMSON REUTERS
·
01 Feb

GlycoMimetics and Crescent Biopharma Announce Merger Plans

TipRanks
·
14 Jan

BRIEF-GlycoMimetics On Dec 19 Nasdaq Grants Glycomimetics 180 Days To Regain Compliance

Reuters
·
27 Dec 2024

GlycoMimetics Inc - on Dec 19, Nasdaq Grants GlycoMimetics 180 Days to Regain Compliance

THOMSON REUTERS
·
27 Dec 2024

Largest borrow rate increases among liquid names

TIPRANKS
·
27 Nov 2024

Largest borrow rate increases among liquid names

TIPRANKS
·
20 Nov 2024

GlycoMimetics: Q3 Earnings Snapshot

Associated Press Finance
·
14 Nov 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

PR Newswire
·
12 Nov 2024

Adage Capital Management Lp Reports 7.9% Stake in GlycoMimetics Inc as of Oct 29 - SEC Filing

THOMSON REUTERS
·
05 Nov 2024